AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Development and Trials of CAR-XT: A New Frontier in Schizophrenia Treatment
This chapter traces the evolution of Xanamaline, an antipsychotic medication, from its initial trials in 2008 to its development into CAR-XT by Karuna Therapeutics. It covers the innovative approach of combining Xanamaline with Trospium to enhance effectiveness and minimize side effects, supported by significant clinical studies.